TY - JOUR
T1 - Challenges and ways of coping of parturient women with chronic hepatitis B in Ghana during COVID-19 pandemic
T2 - a qualitative inquiry
AU - Lanyo, Theresa Norpeli
AU - Ani-Amponsah, Mary
AU - Adjei, Charles Ampong
N1 - Publisher Copyright:
© 2022 BMJ Publishing Group. All rights reserved.
PY - 2022/10/25
Y1 - 2022/10/25
N2 - Objective To explore the psychosocial concerns and ways of coping of pregnant women with chronic hepatitis B infection in Ghana. Setting Participants were selected from public health facilities in the Tema Metropolis. Design Exploratory descriptive qualitative design was employed. Participants Fourteen pregnant women were purposively selected to participate in face-to-face interviews. The data were analysed using the content analysis procedure. Results The participants' psychosocial concerns and coping strategies were diverse. A significant number of the participants were concerned about the impact their hepatitis B seropositivity would have on their relationships, finances, and general well-being. Specifically, they feared that their social network, especially their spouses, would perceive them as having led a promiscuous lifestyle in the past to acquire hepatitis B infection. Also, fear of transmitting the infection to their infants and the effects of the infection on their infants later in life were identified as major concerns by nearly all participants. The participants further reported feelings of distress and diminished self-esteem. These psychosocial afflictions reported were attributed to lack of pre-test counselling during the antenatal care period. However, the participants coped using different strategies, including avoidance/denial, spirituality, and alternative treatment use. Conclusion To achieve optimal psychological and social well-being of pregnant women with chronic hepatitis B, it is important that their unique challenges are considered in their care and treatment cascade. Explicitly, protocols for supportive care addressing the specific needs of pregnant women with chronic hepatitis B should be implemented in the study setting.
AB - Objective To explore the psychosocial concerns and ways of coping of pregnant women with chronic hepatitis B infection in Ghana. Setting Participants were selected from public health facilities in the Tema Metropolis. Design Exploratory descriptive qualitative design was employed. Participants Fourteen pregnant women were purposively selected to participate in face-to-face interviews. The data were analysed using the content analysis procedure. Results The participants' psychosocial concerns and coping strategies were diverse. A significant number of the participants were concerned about the impact their hepatitis B seropositivity would have on their relationships, finances, and general well-being. Specifically, they feared that their social network, especially their spouses, would perceive them as having led a promiscuous lifestyle in the past to acquire hepatitis B infection. Also, fear of transmitting the infection to their infants and the effects of the infection on their infants later in life were identified as major concerns by nearly all participants. The participants further reported feelings of distress and diminished self-esteem. These psychosocial afflictions reported were attributed to lack of pre-test counselling during the antenatal care period. However, the participants coped using different strategies, including avoidance/denial, spirituality, and alternative treatment use. Conclusion To achieve optimal psychological and social well-being of pregnant women with chronic hepatitis B, it is important that their unique challenges are considered in their care and treatment cascade. Explicitly, protocols for supportive care addressing the specific needs of pregnant women with chronic hepatitis B should be implemented in the study setting.
KW - COVID-19
KW - antenatal
KW - hepatology
KW - infection control
KW - infectious diseases & infestations
KW - prenatal diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85140670217&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-062557
DO - 10.1136/bmjopen-2022-062557
M3 - Article
C2 - 36283752
AN - SCOPUS:85140670217
SN - 2044-6055
VL - 12
JO - BMJ Open
JF - BMJ Open
IS - 10
M1 - e062557
ER -